Home ›

Clinical Trials

Neurosearch Amends the ACR-16 Results

Submitted Tue, 06/01/2010
in

The press release below involves a correction to previously announced results of the Huntexil (ACR16) clinical trial in Europe.

The European trial of ACR16 yields good results

Submitted Wed, 02/03/2010
in

ACR16 improves voluntary and involuntary movement. This is wonderful news!

Medivation to begin a Phase III trial of Dimebon

Submitted Wed, 06/03/2009
in

Medivation is sponsoring a randomized, double-Blind, placebo-controlled, Phase III trial of Dimebon in patients with mild to moderate Huntington’s Disease

The Research Pipeline - taking drugs from the lab to the clinic

Submitted Sun, 05/10/2009
in
Here's an overview of some of the more promising potential treatments moving through the research pipeline.

Minocycline Phase II clinical trial results are disappointing

Submitted Thu, 04/23/2009
in
The Huntington Study Group posted the results of its phase II clinical trial of minocycline.

Participants needed for qualitative studies of JHD

Submitted Fri, 07/18/2008
in
The University of Iowa is recruiting participants for two important new studies.

Phase III creatine trial

Submitted Wed, 03/12/2008
in
NCCAM and the Orphan Product Division of the FDA is funding a phase III clinical trial of medicinal grade creatine.

ACR16 closer to Phase III clinical trials

Submitted Mon, 10/01/2007
in
Neurosearch applied for permission to start Phase III clinical trials of ACR16, a dopamine stabilizer, in Europe and the U.S.

Research Study for those At Risk

Submitted Sat, 09/22/2007
in
Last call for participants in an At Risk study.

Riluzole Found Ineffective for Huntington's Disease Patients

Submitted Sun, 08/19/2007
in
A Phase III clinical trial of the glutamate blocker rizuole failed to slow progression or improve symptoms in HD patients.
Syndicate content